Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-06
1997-03-04
Fleisher, Mindy
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, A61K 3818, C07K 14475
Patent
active
056079184
ABSTRACT:
VEGF-B polypeptides from the PDGF family of growth factors having the property of promoting mitosis and proliferation of vascular endothelial cells, DNA sequences encoding these polypeptides, pharmaceutical compositions containing them and antibodies which react with them. The VEGF-B polypeptides are useful in stimulating angiogenesis as well as in diagnostic applications.
REFERENCES:
Klagsburn et al, Ann. Rev. Physiology, 1991, vol. 53: pp. 217-239.
Ferrara et al., J. of Cellular Biochem., 1991, vol. 47: pp. 211-218.
Folkman et al, J. of Biological Chem., Jun., 1992, vol. 267 (16): pp. 10931-10934.
Alitalo Kari
Eriksson Ulf
Olofsson Birgitta
Pajusola Katri
Fleisher Mindy
Helsinki University Licensing Ltd. Oy
Ludwig Institute for Cancer Research
McKelvey Terry A.
LandOfFree
Vascular endothelial growth factor-B and DNA coding therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vascular endothelial growth factor-B and DNA coding therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vascular endothelial growth factor-B and DNA coding therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2146032